New Hampshire 2024 Regular Session

New Hampshire Senate Bill SB560

Introduced
12/14/23  
Refer
12/14/23  
Report Pass
2/22/24  
Engrossed
3/12/24  
Refer
3/12/24  
Report Pass
5/1/24  
Enrolled
6/19/24  
Chaptered
7/10/24  

Caption

Relative to establishing a committee to study the impact of pharmacy benefit manager operations on cost, administration, and distribution of prescription drugs.

Impact

By forming this committee, SB560 seeks to enhance understanding of how PBM practices affect healthcare costs and the accessibility of medications. Specifically, the committee will evaluate claims from PBMs regarding cost savings, the use of clawbacks, and the implications of PBMs steering consumers towards specific pharmacies. These evaluations will involve gathering data on the effects of PBMs on health insurers' overall expenses and assess how plan designs impact consumer prices.

Summary

Senate Bill 560 establishes a committee tasked with studying the impact of pharmacy benefit manager (PBM) operations on the cost, administration, and distribution of prescription drugs in New Hampshire. The bill aims to address concerns surrounding the influence PBMs have on drug pricing and access, which have been increasingly scrutinized in the context of rising healthcare costs. The committee is mandated to investigate various aspects of PBM operations and their relationship with insurers, pharmacies, and consumers, looking to provide insights that could inform future legislative actions.

Contention

The bill is significant as it highlights a growing concern over the role of PBMs within the pharmaceutical supply chain. Advocates for the bill argue that comprehensive oversight and transparency in PBM operations are crucial for reducing costs for consumers and improving their access to medications. However, there may be opposition from PBMs and other stakeholders who could be concerned that increased scrutiny might lead to regulatory burdens or threaten their business models. The outcomes of the committee's study could influence future legislative actions related to pharmacy benefit managers.

Companion Bills

No companion bills found.

Previously Filed As

NH HB383

Relative to provider contract standards for pharmacy benefit managers.

NH HB172

Relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data.

NH SB34

Relative to the controlled drug prescription health and safety program.

NH HB518

Establishing a commission to study revisions to occupational regulation of pharmacists and pharmacies.

NH SB251

Establishing a committee to study the long-term impact of the New Hampshire adult parole system.

NH HB323

Relative to establishing a committee on emerging medical technologies.

NH HB426

Relative to the regulation of pharmacists-in-charge and pharmacies.

NH HB322

Relative to establishing a committee to study the New Hampshire board of medicine.

NH SB159

Establishing a committee to study unlimited service area permits for landfills and out of state waste coming into New Hampshire.

NH HB338

Relative to prescription drug assistance for individuals with diabetes.

Similar Bills

NJ AR96

Changes membership of Budget and Labor Committees; clarifies that bill or resolution may be listed on committee agenda for purposes of amendment.

MI HB4326

Campaign finance: contributions and expenditures; provision related to officeholders raising funds when facing a recall; modify, and require candidate to establish a separate account used for recall purposes. Amends secs. 3, 11, 12, 21, 24 & 52 of 1976 PA 388 (MCL 169.203 et seq.) & adds sec. 21b.

MI HB4870

Campaign finance: contributions and expenditures; funds donated to a candidate for recall efforts; require candidate to establish a separate account used for recall purposes. Amends secs. 3, 11, 12, 21, 24 & 52 of 1976 PA 388 (MCL 169.203 et seq.) & adds sec. 21b.

MN HC6

A concurrent resolution recognizing wild rice as sacred and central to the culture and health of Indigenous Peoples in Minnesota and critical to the health and identity of all Minnesota citizens and ecosystems and establishing a commitment to passing legislation to protect wild rice and the freshwater resources upon which it depends.

CA SB1048

Advisory bodies.

CA SB602

Advisory bodies.

CA AB3239

Advisory bodies.

KS HR6003

Providing temporary rules of the House of Representatives for the 2023 session until permanent rules are adopted.